Gemalto advances secure communications for Financial

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Gemalto advances secure communications for Financial Services industry with Symphony Platform Integration

AMSTERDAM, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Gemalto (Euronext NL0000400653 GTO), the world leader in digital security, today announced the integration of its industry-leading SafeNet Hardware Security Modules (HSM) with Symphony Communication Services’ secure cloud-based communications platform. Available through Symphony’s app ecosystem, the SafeNet HSM protects the cryptographic root of trust for secure and confidential communications for highly-regulated organizations using the Symphony platform. Gemalto recently presented its contribution to the platform at Symphony Innovate 2016 , an invite-only industry conference dedicated to strategizing on the future of work and how enterprises are driving this transformation through Symphony’s communications platform.

“Symphony delivers a secure compliant productivity and collaboration platform whose entire ecosystem—from content owners, to trading platforms, to finserv companies—depends on the best security available,” says Frederic Stemmelin, Symphony’s Vice President of Business Development. “Gemalto’s state-of-the-art encryption technology meets the modern standard of security that our platform demands.”

Data security is one of the primary challenges facing the financial services industry. According to Gemalto’s latest Breach Level Index report, breaches affecting the industry accounted for 12 percent of all breaches during the first six months of 2016, a period during which the total number of data breaches rose by 15 percent compared to the last six months of 2015.

The Gemalto SafeNet HSM is a dedicated crypto processor that securely manages, processes and stores cryptographic keys inside of a hardened, tamper-resistant device. Symphony’s customers can deploy a SafeNet Network HSM in their data center or purchase Cloud HSM in an Amazon Web Services (AWS) cloud environment or through Google Cloud Platform, using it to manage and secure encryption keys and cryptographic operations in order to protect communications and maintain compliance.

Whether it’s via secure text, chat, email, voice, or video, Symphony with Gemalto secures communications with FIPS 104-2 Level 3 assurances, ensuring regulatory compliance and protection for data in motion and at rest. Symphony’s integration with the SafeNet HSM gives the customer the ability to manage access to specific conversations by assigning or revoking credentials for appropriate participants as needed.

“Working with Symphony is the logical choice for helping financial institutions protect all sensitive data, regardless of where it’s stored or how it gets shared,” said Todd Moore, Senior Vice President for Encryption Products at Gemalto. “These organizations now have the ability to fully own the keys that encrypt data in every environment in their infrastructure where the Symphony platform is deployed, all while employees enjoy the convenience and productivity capabilities of a streamlined workflow.”

Related Resources

About Gemalto

Gemalto (Euronext NL0000400653 GTO) is the global leader in digital security, with 2015 annual revenues of €3.1 billion and customers in over 180 countries. We bring trust to an increasingly connected world.

Our technologies and services enable businesses and governments to authenticate identities and protect data so they stay safe and enable services in personal devices, connected objects, the cloud and in between.

Gemalto’s solutions are at the heart of modern life, from payment to enterprise security and the internet of things. We authenticate people, transactions and objects, encrypt data and create value for software – enabling our clients to deliver secure digital services for billions of individuals and things.

Our 14,000+ employees operate out of 118 offices, 45 personalization and data centers, and 27 research and software development centers located in 49 countries.

For more information visit www.gemalto.com or follow @gemalto on Twitter.

Gemalto media contacts:

Philippe Benitez North America +1 512 257 3869 philippe.benitez@gemalto.com     Peggy Edoire Europe & CIS +33 4 42 36 45 40 peggy.edoire@gemalto.com     Vivian Liang 大中华地区 (Greater China) +86 1059373046 vivian.liang@gemalto.com
             
Ernesto Haikewitsch Latin America +55 11 5105 9220 ernesto.haikewitsch@gemalto.com     Kristel Teyras Middle East & Africa +33 1 55 01 57 89 kristel.teyras@gemalto.com     Shintaro Suzuki Asia Pacific +65 6317 8266   shintaro.suzuki@gemalto.com

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading